When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
Simulations of a real-world explanatory trial of transarterial radioembolization for advanced unresectable hepatocellular carcinoma with portal vein invasion were performed to examine the effects of ...
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...
New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...
Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...
As decentralized and flexible clinical trial models mature, they have become an established component of research and ...
An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...
Some industry-funded clinical trials show signs of being designed to market drugs rather than to test them for their safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results